Geneos Wealth Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17
| Closed | – | – | 2069 |
|
|
2022
Q3 | $0 | Sell |
17
-12
| -41% | – | ﹤0.01% | 2386 |
|
|
2022
Q2 | $1K | Hold |
29
| – | – | ﹤0.01% | 2520 |
|
|
2022
Q1 | $2K | Hold |
29
| – | – | ﹤0.01% | 2559 |
|
|
2021
Q4 | $5K | Sell |
29
-7
| -19% | -$1.21K | ﹤0.01% | 2408 |
|
|
2021
Q3 | $9K | Hold |
36
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q2 | $9K | Hold |
36
| – | – | ﹤0.01% | 2235 |
|
|
2021
Q1 | $10K | Hold |
36
| – | – | ﹤0.01% | 2387 |
|
|
2020
Q4 | $10K | Sell |
36
-24
| -40% | -$6.67K | ﹤0.01% | 2219 |
|
|
2020
Q3 | $15K | Hold |
60
| – | – | ﹤0.01% | 1790 |
|
|
2020
Q2 | $19K | Hold |
60
| – | – | ﹤0.01% | 1646 |
|
|
2020
Q1 | $15K | Hold |
60
| – | – | ﹤0.01% | 1633 |
|
|
2019
Q4 | $19K | Hold |
60
| – | – | ﹤0.01% | 1707 |
|
|
2019
Q3 | $16K | Sell |
60
-10
| -14% | -$2.67K | ﹤0.01% | 1711 |
|
|
2019
Q2 | $37K | Sell |
70
-7
| -9% | -$3.7K | ﹤0.01% | 1344 |
|
|
2019
Q1 | $38K | Hold |
77
| – | – | ﹤0.01% | 1275 |
|
|
2018
Q4 | $38K | Sell |
77
-5
| -6% | -$2.47K | ﹤0.01% | 1226 |
|
|
2018
Q3 | $75K | Hold |
82
| – | – | 0.01% | 989 |
|
|
2018
Q2 | $60K | Buy |
82
+39
| +91% | +$28.5K | ﹤0.01% | 965 |
|
|
2018
Q1 | $68K | Buy |
+43
| New | +$68K | 0.01% | 885 |
|